Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machaon Bonafede

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|November 2, 2022
Relative Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Adults During the 2019-2020 Influenza Season in the United StatesMahrukh Imran, Justin R Ortiz, Huong Q McLean, et al.
The Pediatric Infectious Disease Journal|July 7, 2022
Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019-2020 Influenza SeasonMahrukh Imran, Justin R Ortiz, Huong Q McLean, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Factors Associated with Direct Health Care Costs Among Patients with MigraineMachaon Bonafede, Qian Cai, Katherine Cappell, et al.
Influenza and Other Respiratory Viruses|April 22, 2024
Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza SeasonMahrukh Imran, Joan Puig-Barbera, Justin R Ortiz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 7, 2010
Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of lifeTheresa W Guilbert, Cindy Garris, Priti Jhingran, et al.
Open Forum Infectious Diseases|May 2, 2022
Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019-2020 Influenza SeasonMahrukh Imran, Joan Puig-Barbera, Justin R Ortiz, et al.
Diabetes, Obesity & Metabolism|March 14, 2025
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® databaseTheresa Hunter Gibble, Chanadda Chinthammit, Jennifer M Ward, et al.
Diseases (Basel, Switzerland)|January 22, 2024
Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall-Winter 2022-2023: A Cross-Sectional Retrospective StudyHagit Kopel, Alina Bogdanov, Jessamine P Winer-Jones, et al.
Infectious Diseases and Therapy|January 10, 2026
Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort StudyNevena Vicic, Alina Bogdanov, Zhe Zheng, et al.
Infectious Diseases and Therapy|June 24, 2026
Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United StatesNevena Vicic, Alina Bogdanov, Heather Hensler, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|November 2, 2022
Relative Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Adults During the 2019-2020 Influenza Season in the United StatesMahrukh Imran, Justin R Ortiz, Huong Q McLean, et al.
The Pediatric Infectious Disease Journal|July 7, 2022
Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019-2020 Influenza SeasonMahrukh Imran, Justin R Ortiz, Huong Q McLean, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Factors Associated with Direct Health Care Costs Among Patients with MigraineMachaon Bonafede, Qian Cai, Katherine Cappell, et al.
Influenza and Other Respiratory Viruses|April 22, 2024
Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza SeasonMahrukh Imran, Joan Puig-Barbera, Justin R Ortiz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 7, 2010
Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of lifeTheresa W Guilbert, Cindy Garris, Priti Jhingran, et al.
Open Forum Infectious Diseases|May 2, 2022
Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019-2020 Influenza SeasonMahrukh Imran, Joan Puig-Barbera, Justin R Ortiz, et al.
Diabetes, Obesity & Metabolism|March 14, 2025
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® databaseTheresa Hunter Gibble, Chanadda Chinthammit, Jennifer M Ward, et al.
Diseases (Basel, Switzerland)|January 22, 2024
Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall-Winter 2022-2023: A Cross-Sectional Retrospective StudyHagit Kopel, Alina Bogdanov, Jessamine P Winer-Jones, et al.
Infectious Diseases and Therapy|January 10, 2026
Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort StudyNevena Vicic, Alina Bogdanov, Zhe Zheng, et al.
Infectious Diseases and Therapy|June 24, 2026
Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United StatesNevena Vicic, Alina Bogdanov, Heather Hensler, et al.
Pageof 10